Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
106857493 | 10685749 | 3 | F | 2000 | 20160815 | 20141231 | 20160824 | EXP | US-009507513-1204USA04480 | MERCK | 0.00 | M | Y | 82.86000 | KG | 20160824 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
106857493 | 10685749 | 1 | PS | PROPECIA | FINASTERIDE | 1 | Oral | 1 MG, UNK | U | 20788 | 1 | MG | FILM-COATED TABLET | ||||||
106857493 | 10685749 | 2 | SS | PROSCAR | FINASTERIDE | 1 | Oral | 5 MG, UNK | U | 0 | 5 | MG | FILM-COATED TABLET | ||||||
106857493 | 10685749 | 3 | SS | PROSCAR | FINASTERIDE | 1 | U | 0 | FILM-COATED TABLET | ||||||||||
106857493 | 10685749 | 4 | SS | FINASTERIDE. | FINASTERIDE | 1 | Oral | 5 MG, DAILY | U | 0 | 5 | MG | TABLET | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
106857493 | 10685749 | 1 | Alopecia |
106857493 | 10685749 | 2 | Benign prostatic hyperplasia |
106857493 | 10685749 | 3 | Alopecia |
106857493 | 10685749 | 4 | Alopecia |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
106857493 | 10685749 | HO |
106857493 | 10685749 | OT |
106857493 | 10685749 | DS |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
106857493 | 10685749 | Abnormal loss of weight | |
106857493 | 10685749 | Acne | |
106857493 | 10685749 | Actinic keratosis | |
106857493 | 10685749 | Anxiety | |
106857493 | 10685749 | Arthralgia | |
106857493 | 10685749 | Asthenia | |
106857493 | 10685749 | Astigmatism | |
106857493 | 10685749 | Back disorder | |
106857493 | 10685749 | Back pain | |
106857493 | 10685749 | Benign prostatic hyperplasia | |
106857493 | 10685749 | Cognitive disorder | |
106857493 | 10685749 | Colonoscopy | |
106857493 | 10685749 | Corneal scar | |
106857493 | 10685749 | Decreased appetite | |
106857493 | 10685749 | Depression | |
106857493 | 10685749 | Diarrhoea | |
106857493 | 10685749 | Drug administration error | |
106857493 | 10685749 | Ejaculation disorder | |
106857493 | 10685749 | Ejaculation failure | |
106857493 | 10685749 | Erectile dysfunction | |
106857493 | 10685749 | Essential hypertension | |
106857493 | 10685749 | Haematochezia | |
106857493 | 10685749 | Haemorrhoids | |
106857493 | 10685749 | Hyalosis asteroid | |
106857493 | 10685749 | Hypercholesterolaemia | |
106857493 | 10685749 | Hypothyroidism | |
106857493 | 10685749 | Infection | |
106857493 | 10685749 | Intervertebral disc displacement | |
106857493 | 10685749 | Libido decreased | |
106857493 | 10685749 | Ligament sprain | |
106857493 | 10685749 | Limb injury | |
106857493 | 10685749 | Lumbar radiculopathy | |
106857493 | 10685749 | Muscle spasms | |
106857493 | 10685749 | Presbyopia | |
106857493 | 10685749 | Prostatic specific antigen increased | |
106857493 | 10685749 | Renal disorder | |
106857493 | 10685749 | Rosacea | |
106857493 | 10685749 | Rotator cuff syndrome | |
106857493 | 10685749 | Sexual dysfunction | |
106857493 | 10685749 | Tendonitis | |
106857493 | 10685749 | Type 2 diabetes mellitus | |
106857493 | 10685749 | Vitamin D deficiency |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
106857493 | 10685749 | 1 | 2000 | 0 | ||
106857493 | 10685749 | 2 | 2010 | 201111 | 0 | |
106857493 | 10685749 | 4 | 20111121 | 0 |